2021 World Conference on Lung Cancer (Posters)-FP12. Clinico-demographic Factors, EGFR status and their association with Stage at Diagnosis in Lung Adenocarcinoma Patients

FP12. Clinico-demographic Factors, EGFR status and their association with Stage at Diagnosis in Lung Adenocarcinoma Patients

Back to course

Video Transcription

Video Summary

Josh Herman, a medical student at the University of Toronto, presented a study on the association between clinical demographic factors, EGFR status, and the stage of lung adenocarcinoma diagnosis. The study found that EGFR positive lung adenocarcinomas are more common in younger Asian females and non-smokers. However, there was no association between EGFR mutation status and stage of diagnosis. Male sex, non-Caucasian ethnicity, and smoking were independently associated with a higher stage of disease diagnosis. Further research is needed to understand these disparities and improve early detection of lung adenocarcinomas.

Asset Subtitle

Joshua E Herman

Meta Tag

Speaker Joshua E Herman

Topic Predictive Tumor Based Assays/ Biomarkers/ Pathology

Keywords

EGFR status

lung adenocarcinoma diagnosis

EGFR positive

non-smokers

higher stage of disease diagnosis